Hormone Receptor Positive Breast Carcinoma

Also known as: Hormone-receptor Positive Breast Cancer / Hormone Receptor-Positive Breast Cancer / Hormone Receptor (HR)-Positive Breast Cancer / Hormone-receptors Positive Breast Cancer / Hormone Receptor Positive Breast Cancer

DrugDrug NameDrug Description
DB09074OlaparibA poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.
DrugDrug NamePhaseStatusCount
DB06374Elacestrant0Completed1
DB12565Abexinostat1Withdrawn1
DB05812Abiraterone1Active Not Recruiting1
DB11595Atezolizumab1Active Not Recruiting1
DB11945Avelumab1Active Not Recruiting1
DB06616Bosutinib1Active Not Recruiting1
DB01101Capecitabine1Active Not Recruiting1
DB14707Cemiplimab1Active Not Recruiting1
DB16410Datopotamab deruxtecan1Recruiting1
DB17573Evorpacept1Recruiting1
DB11679Fruquintinib1Active Not Recruiting1
DB00947Fulvestrant1Active Not Recruiting2
DB00947Fulvestrant1Not Yet Recruiting2
DB00947Fulvestrant1Recruiting1
DB00947Fulvestrant1Withdrawn1
DB01006Letrozole1Not Yet Recruiting1
DB01006Letrozole1Recruiting1
DB09035Nivolumab1Recruiting1
DB01229Paclitaxel1Withdrawn1
DB09073Palbociclib1Active Not Recruiting1
DB09073Palbociclib1Withdrawn1
DB00635Prednisone1Active Not Recruiting1
DB14962Trastuzumab deruxtecan1Recruiting1
DB16342Trastuzumab duocarmazine1Withdrawn1
DB11652Tucatinib1Recruiting1
DB15471Zanidatamab1Recruiting1
DB17525Zanzalintinib1Active Not Recruiting1
DB12001Abemaciclib1 / 2Recruiting1
DB15254Avutometinib1 / 2Recruiting1
DB01590Everolimus1 / 2Completed1
DB00990Exemestane1 / 2Completed1
DB00947Fulvestrant1 / 2Recruiting1
DB12570Onatasertib1 / 2Completed1
DB09073Palbociclib1 / 2Completed1
DB12001Abemaciclib2Active Not Recruiting1
DB12001Abemaciclib2Recruiting4
DB12001Abemaciclib2Terminated1
DB12015Alpelisib2Recruiting1
DB01217Anastrozole2Recruiting5
DB18290Anvatabart opadotin2Not Yet Recruiting1
DB00958Carboplatin2Recruiting1
DB11073Cetylpyridinium2Completed1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Recruiting2
DB06699Degarelix2Recruiting1
DB01234Dexamethasone2Completed1
DB01248Docetaxel2Active Not Recruiting1
DB01248Docetaxel2Recruiting1
DB00997Doxorubicin2Recruiting2
DB00445Epirubicin2Active Not Recruiting1
DB00445Epirubicin2Recruiting1
DB01590Everolimus2Completed1
DB00990Exemestane2Completed1
DB00990Exemestane2Recruiting2
DB00990Exemestane2Withdrawn1
DB00947Fulvestrant2Active Not Recruiting1
DB00947Fulvestrant2Recruiting3
DB00947Fulvestrant2Terminated1
DB06205Hyaluronidase (human recombinant)2Recruiting2
DB01006Letrozole2Completed1
DB01006Letrozole2Recruiting3
DB00007Leuprolide2Recruiting1
DB01229Paclitaxel2Recruiting2
DB09073Palbociclib2Recruiting1
DB06589Pazopanib2Withdrawn1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting2
DB14993Pyrotinib2Active Not Recruiting1
DB14993Pyrotinib2Recruiting1
DB11730Ribociclib2Recruiting2
DB12893Sacituzumab govitecan2Not Yet Recruiting1
DB00675Tamoxifen2Recruiting3
DB00072Trastuzumab2Active Not Recruiting1
DB00072Trastuzumab2Recruiting2
DB14962Trastuzumab deruxtecan2Recruiting1
DB01217Anastrozole3Active Not Recruiting1
DB00531Cyclophosphamide3Recruiting1
DB00997Doxorubicin3Recruiting1
DB00445Epirubicin3Recruiting1
DB00947Fulvestrant3Active Not Recruiting1
DB01229Paclitaxel3Recruiting1
DB14993Pyrotinib3Recruiting1
DB11730Ribociclib4Recruiting1
DB00014GoserelinNot AvailableNot Yet Recruiting1
DB00007LeuprolideNot AvailableNot Yet Recruiting1
DB00675TamoxifenNot AvailableNot Yet Recruiting1
DB00539ToremifeneNot AvailableNot Yet Recruiting1